Sign in and upgrade to a paid plan to export futures history as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.

Indegene Limited

Healthcare · Healthcare Services

NSE: INDGN BSE: 544172

About Indegene Limited

Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics.

Source: Wikipedia

Key facts

BSE symbol544172
NSE symbolINDGN
ISININE065X01017
CINL73100KA1998PLC102040
Listing date13 May 2024
Fiscal year end31 Mar
SectorHealthcare
IndustryHealthcare Services
AuditorMadhwesh Prathap & Associates (Madhwesh. K)
Registered officeThird Floor, Aspen G-4 Block, Manyata Embassy Business Park (SEZ), Outer Ring Road, Nagawara, Bengaluru- 560 045, Karnataka, India
Index memberships

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24
Total income (before exceptional items)1,299†1,187†—
Net profit212181138

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Manish GuptaExecutive DirectorJune 30, 2026
Sanjay Suresh ParikhExecutive DirectorJune 30, 2026
Ashish GuptaIndependent DirectorJune 30, 2026
Georgia Nikolakopoulou PapathomasIndependent DirectorJune 30, 2026
Jairaj Manohar PurandareIndependent DirectorJune 30, 2026
Jill Mary De SimoneIndependent DirectorJune 30, 2026
Krishnamurthy Venugopala TennetiIndependent DirectorJune 30, 2026
Neeraj BharadwajIndependent DirectorJune 30, 2026
Pravin Udhyavara Bhadya RaoIndependent DirectorJune 30, 2026
Mark Francis DzialgaNon-Executive DirectorJune 30, 2026
Rajesh Bhaskaran NairNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.